NMN vs NR: Which Is Right for Your Formulation?

Overview

Both NMN (β-Nicotinamide Mononucleotide, CAS 1094-61-7) and NR (Nicotinamide Riboside, CAS 1341-23-7) are NAD⁺ precursors widely used in longevity, sports nutrition, and pharmaceutical formulations. For formulators sourcing in bulk, the differences go beyond marketing — they affect your COA specifications, stability testing protocols, and regulatory submissions.

Molecular Pathway

NR is converted to NMN in the cell before being converted to NAD⁺. NMN enters the NAD⁺ biosynthesis pathway one step closer to the final molecule. NMN has a higher molecular weight (334.22 g/mol vs 255.25 g/mol for NR), meaning equivalent molar doses require ~31% more mass. NMN is typically more expensive per kilogram due to more complex synthesis routes.

Purity and Analytical Standards

The industry standard purity for commercial-grade NMN and NR is approximately 98–98.5% by HPLC. At PathGene, our enzymatic synthesis process consistently delivers ≥99.5% purity — verified by third-party labs. Key impurities to check: Nicotinamide (NAM), Nicotinic acid (NA), Heavy metals (Pb, As, Hg, Cd).

Stability

Both molecules are hygroscopic. Recommended storage: 2–8°C, sealed, away from light. NMN is generally slightly more stable than NR in finished formulations.

Regulatory Status

NMN: As of 2025, generally permissible as a dietary supplement ingredient in most jurisdictions. Pharmaceutical use requires IND/NDA filings. NR: Established GRAS status in the US, available without restriction in most markets.

Which Should You Choose?

Choose NMN if your target market values next-generation NAD⁺ precursor positioning. Choose NR if cost-efficiency is a priority. We supply both. Request an NMN sample or request an NR sample.